Cite

    Adimadhyam, S. et al. (2019). Increased risk of mycotic infections associated with sodium–glucose co‐transporter 2 inhibitors: a prescription sequence symmetry analysis. British journal of clinical pharmacology. 85 (1), pp. 160-168. [Online].